90
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Tool for assessment of attitudes for applying a new approach in the decision-making process for reimbursement list in Bosnia and Herzegovina

, &
Article: 2349593 | Received 28 Dec 2023, Accepted 25 Apr 2024, Published online: 06 May 2024
 

Abstract

The healthcare structure in Bosnia and Herzegovina is decentralized, thus facing patients with unequal access to healthcare services especially for medicines. We attempted to develop a tool for assessment of the stakeholders’ opinion, and with the further research we will propose the model that can bring equality in Bosnia and Herzegovina. The developed tool will examine the attitudes and opinions for introducing new methods in the decision-making process during the listing of medicines for the reimbursement list in Bosnia and Herzegovina. An update of the country’s legislation can be presented based on the research results. The tool was developed using the Delphi method. The experts who were included in the Delphi panel are qualified for rating and discussing questions. The questionnaire was validated on a 5-point Likert scale, and additional comments or clarification are optional. Introductory interviews were held face to face with each expert individually; after that the panel was anonymous. After 3 rounds of Delphi, the created tool was checked through a pilot study. The developed tool was categorized into three groups based on the KAP survey (Knowledge, Attitudes, Perceptions). All questions were verified in pilot and with the results for Cronbach’s alpha 0.96. This shows sufficient reliability of the created questionnaire, and it can be administered to a larger group of respondents, which has been planned for further research. The findings provide reliable information useful for planning the country’s legislation updates and planning for the introduction of a new approach in the decision-making process.

Acknowledgments

The authors thank all the panelists who took part in the Delphi rating process and the individuals who contributed to the study.

Authors contributions

S.B., conception and design of the work, supervision, acquisition, analysis, interpretation of data, origial draft preparation; B.V, acquisition, analysis of data, writing; V. M., conception and design of the work, critical review for important intellectual content. All authors have read and approved the final version of the paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author, SB, upon reasonable request.

Additional information

Funding

This research was funded by the Ministry of Science, Technological Development and Innovation, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: [451-03-47/2023-01/200161].
Publication of study results was not contingent on the sponsor’s approval or censorship of the manuscript.
The funder had no role in the design and conducting of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.